Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15890415rdf:typepubmed:Citationlld:pubmed
pubmed-article:15890415lifeskim:mentionsumls-concept:C0019682lld:lifeskim
pubmed-article:15890415lifeskim:mentionsumls-concept:C0019699lld:lifeskim
pubmed-article:15890415lifeskim:mentionsumls-concept:C0521026lld:lifeskim
pubmed-article:15890415lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:15890415lifeskim:mentionsumls-concept:C0028621lld:lifeskim
pubmed-article:15890415lifeskim:mentionsumls-concept:C0079866lld:lifeskim
pubmed-article:15890415lifeskim:mentionsumls-concept:C1707689lld:lifeskim
pubmed-article:15890415pubmed:issue1lld:pubmed
pubmed-article:15890415pubmed:dateCreated2005-6-13lld:pubmed
pubmed-article:15890415pubmed:abstractTextWe report the activities of a novel nucleoside analog against HIV. This nucleoside (KP-1212) is not a chain terminator but exerts its antiviral effects via mutagenesis of the viral genome. Serial passaging of HIV in the presence of KP-1212 causes an increase in the mutation rate of the virus leading to viral ablation. HIV strains resistant to KP-1212 have not yet been isolated. Quite to the contrary, virus treated with KP-1212 exhibited an increased sensitivity not only to KP-1212 but also to another nucleoside reverse transcriptase inhibitor (NRTI), zidovudine. HIV strains resistant to other NRTIs (e.g. zidovudine, lamivudine, stavudine, abacavir, etc.) exhibited no cross-resistance towards KP-1212. Multiple assays confirmed that KP-1212 has a favorable (low) genotoxicity profile when compared to some approved antiviral nucleosides. In addition, KP-1212 is not toxic to mitochondria nor does it exhibit any inhibitory effects on mitochondrial DNA synthesis.lld:pubmed
pubmed-article:15890415pubmed:languageenglld:pubmed
pubmed-article:15890415pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15890415pubmed:citationSubsetIMlld:pubmed
pubmed-article:15890415pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15890415pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15890415pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15890415pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15890415pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15890415pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15890415pubmed:statusMEDLINElld:pubmed
pubmed-article:15890415pubmed:monthJullld:pubmed
pubmed-article:15890415pubmed:issn0166-3542lld:pubmed
pubmed-article:15890415pubmed:authorpubmed-author:DaifukuRichar...lld:pubmed
pubmed-article:15890415pubmed:authorpubmed-author:HarrisKevin...lld:pubmed
pubmed-article:15890415pubmed:authorpubmed-author:BrabantWillia...lld:pubmed
pubmed-article:15890415pubmed:authorpubmed-author:StyrchakSheil...lld:pubmed
pubmed-article:15890415pubmed:authorpubmed-author:GallAlexander...lld:pubmed
pubmed-article:15890415pubmed:issnTypePrintlld:pubmed
pubmed-article:15890415pubmed:volume67lld:pubmed
pubmed-article:15890415pubmed:ownerNLMlld:pubmed
pubmed-article:15890415pubmed:authorsCompleteYlld:pubmed
pubmed-article:15890415pubmed:pagination1-9lld:pubmed
pubmed-article:15890415pubmed:dateRevised2007-9-12lld:pubmed
pubmed-article:15890415pubmed:meshHeadingpubmed-meshheading:15890415...lld:pubmed
pubmed-article:15890415pubmed:meshHeadingpubmed-meshheading:15890415...lld:pubmed
pubmed-article:15890415pubmed:meshHeadingpubmed-meshheading:15890415...lld:pubmed
pubmed-article:15890415pubmed:meshHeadingpubmed-meshheading:15890415...lld:pubmed
pubmed-article:15890415pubmed:meshHeadingpubmed-meshheading:15890415...lld:pubmed
pubmed-article:15890415pubmed:meshHeadingpubmed-meshheading:15890415...lld:pubmed
pubmed-article:15890415pubmed:meshHeadingpubmed-meshheading:15890415...lld:pubmed
pubmed-article:15890415pubmed:meshHeadingpubmed-meshheading:15890415...lld:pubmed
pubmed-article:15890415pubmed:meshHeadingpubmed-meshheading:15890415...lld:pubmed
pubmed-article:15890415pubmed:meshHeadingpubmed-meshheading:15890415...lld:pubmed
pubmed-article:15890415pubmed:meshHeadingpubmed-meshheading:15890415...lld:pubmed
pubmed-article:15890415pubmed:meshHeadingpubmed-meshheading:15890415...lld:pubmed
pubmed-article:15890415pubmed:meshHeadingpubmed-meshheading:15890415...lld:pubmed
pubmed-article:15890415pubmed:year2005lld:pubmed
pubmed-article:15890415pubmed:articleTitleKP-1212/1461, a nucleoside designed for the treatment of HIV by viral mutagenesis.lld:pubmed
pubmed-article:15890415pubmed:affiliationKoronis Pharmaceuticals Inc., 12277 134th Ct. N.E. Redmond, WA 98052, USA. kharris@koronispharma.comlld:pubmed
pubmed-article:15890415pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15890415lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15890415lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15890415lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15890415lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15890415lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15890415lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15890415lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15890415lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15890415lld:pubmed